Guardant Health, Inc. Common Stock (GH) is a publicly traded Healthcare sector company. As of October 8, 2026, GH trades at $165.82 with a market cap of $22.59B and a P/E ratio of -50.57. GH moved -1.61% today. Year to date, GH is +62.73%; over the trailing twelve months it is +153.46%. Its 52-week range spans $34.88 to $191.05. Analyst consensus is strong buy with an average price target of $202.00. Rallies surfaces GH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for GH, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $165.82 |
| Market Cap | $22.59B |
| P/E Ratio | -50.57 |
| EPS | $-3.51 |
| Dividend Yield | 0.00% |
| 52-Week High | $191.05 |
| 52-Week Low | $34.88 |
| Volume | 1.41M |
| Avg Volume | 0 |
| Revenue (TTM) | $1.18B |
| Net Income | $-453.44M |
| Gross Margin | 65.01% |
21 analysts cover GH: 0 strong buy, 21 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $202.00.